Hummingbird Bioscience Initiates HMBD-001 Phase IB Trials in Australia and Partners with Omico to…
Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, announced the initiation…
Read More...
Read More...